These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18277458)

  • 1. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
    Rigel DS; Torres AM; Ely H
    J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
    Tillman DK; Carroll MT
    J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s7-14. PubMed ID: 18277457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma.
    Wu JK; Oh C; Strutton G; Siller G
    Australas J Dermatol; 2006 Feb; 47(1):46-8. PubMed ID: 16405483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
    Spencer JM
    Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas.
    Berman B
    J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s3-6. PubMed ID: 18277456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
    Quirk C; Gebauer K; Owens M; Stampone P
    Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
    Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
    Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
    Schiessl C; Wolber C; Tauber M; Offner F; Strohal R
    J Drugs Dermatol; 2007 May; 6(5):507-13. PubMed ID: 17679185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
    Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nodular basal cell carcinoma with cryotherapy and reduced protocol of imiquimod.
    Moutran R; Maatouk I; Stephan F; Tomb R
    Cutis; 2012 Nov; 90(5):256-7. PubMed ID: 23270198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
    Ruiz ES; Cohen JL; Friedman A
    J Drugs Dermatol; 2015 May; 14(5):450-2. PubMed ID: 25942661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current modalities and new advances in the treatment of basal cell carcinoma.
    Ceilley RI; Del Rosso JQ
    Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large facial basal cell carcinoma treated with multimodal combination therapy.
    Rubenzik MK; Schwartz LR; Humphreys TR
    Cutis; 2011 Oct; 88(4):182-4. PubMed ID: 22106726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy.
    Dixon AJ
    Aust Fam Physician; 2005; 34(1-2):49-52. PubMed ID: 15727358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
    Thissen MR; Kuijpers DI; Krekels GA
    J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
    Butler DF; Parekh PK; Lenis A
    Dermatol Surg; 2009 Jan; 35(1):24-9. PubMed ID: 19018814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial.
    Sinx KAE; Nelemans PJ; Kelleners-Smeets NWJ; Winnepenninckx VJL; Arits AHMM; Mosterd K
    J Am Acad Dermatol; 2020 Aug; 83(2):469-476. PubMed ID: 32320773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
    MacFarlane DF; El Tal AK
    Arch Dermatol; 2011 Nov; 147(11):1326-7. PubMed ID: 22106125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.